ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ZSTK vs HKPD // ENTERPRISE SCALE & MARKET CAP

ZeroStack Corp. (NASDAQ) VS. Cellyan Biotechnology Co. Ltd (Class A) (NASDAQ) • 15-METRIC TALLY: ZSTK 1 — HKPD 1
▲ ENTERPRISE SCALE & MARKET CAP LEADER: ZSTK
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZSTK VS. HKPD) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ZSTK HKPD SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 4.60% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% — — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -13.77% — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin — — — TIE /net-margins <GO>
Revenue Growth (YoY) -0.50% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 — — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 25.0 35.5 -10.55 HKPD /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $63.9M $5.4M $58.5M ZSTK /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ZSTK REV HKPD REV ZSTK GROSS % HKPD GROSS % ZSTK FCF HKPD FCF
FY 2025 $35.7M — 4.6% — -$8.8M —
FY 2024 $35.9M — 6.1% — -$5.2M —
FY 2023 $76.1M — — — -$8.4M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZSTK // BETA —
HKPD // BETA —